New Rheumatoid Arthritis Drugs Work Better Than Standard Anti-inflammatories, Study Suggests

The latest class of drugs used to treat rheumatoid arthritis are better than standard anti-inflammatories, according to a new study. Analysis of the combined results of thirteen trials showed that anti-TNF± drugs, given at recommended doses, were better than the usual treatments, such as methotrexate, for treating RA. Patients who had previously seen little benefit from methotrexate alone showed a better response with combined anti-TNF± plus methotrexate therapy.